Tag: anticoagulant
Phase I study initiated to evaluate a new precision oral anticoagulant...
The first-in-human phase I trial will take place in Australia for Verseon’s PROAC (PRecision Oral AntiCoagulant) VE-1902, which has successfully completed regulatory toxicology studies...
New guidelines promote safety for patients on antithrombotic drugs undergoing anaesthesia...
Patient safety is the focus of newly published updates to consensus statements that address the use of antithrombotic drugs by individuals who may require...
Four out of 10 AF patients may not receive necessary stroke-prevention...
Many patients with an irregular heartbeat, known as atrial fibrillation, are not receiving recommended blood thinning medication they need to prevent strokes, according to...
Bristol-Myers Squibb and Pfizer to present new apixaban analyses at ESC
Bristol-Myers Squibb and Pfizer have announced that 19 abstracts (late-breaking, rapid-fire, oral and poster presentations) on apixaban (Eliquis) will be presented at the European...